NEWS

Corporate Governance Policy (Revised)

• Investor

Cooperative Support for the Kyoto World Water Grand Prize

• News & Notices

Using AI to Support Laboratory Practice Reforms at Research Sites
Shimadzu Releases Peakintelligence Ver. 2.1 AI Software for LC-MS/MS

• Product & Event info
• News & Notices

Utility of World's first Robot-compatible Autonomous Laboratory System with LC and LC-MS Units Verified with Kobe University

• News & Notices

Shimadzu RSNA2021(Radiological Society of North America) report / Thank you for joining!

• Product & Event info

Release of Gear Pumps with a Low-Noise Design, Supporting the Need for a Switch to Electric Motors
Adopted by Major Manufacturers of Forklifts in Europe

• Product & Event info
• News & Notices

Shimadzu Releases New Version of Its Cell Pocket Web Application for Supporting Cell Observation
Cell Image Management and Analysis Software Augmented by AI (Deep Learning)

• Product & Event info
• News & Notices

Expanding Market Share by Entering High-End Market
Release of Six New AP-AD Series Analytical Balances

• Product & Event info
• News & Notices

Shimadzu Receives First Award for Fragrance Oil and Diffuser Set Derived from Shimadzu Environmental Activities and Created Using Traditional Kyoto Craft Arts
- Red Dot Award: Brands & Communication Design 2021 -

• News & Notices

Shimadzu Customer Service Center Established to Expand Business Activities Related to Medical Systems in China
Aiming to Provide New Consultant Style Service

• News & Notices

Enabling the Development of Optimal Analytical Methods
Release of LabSolutions MD, Support Software for Analytical Method Development for High-Performance Liquid Chromatography

• Product & Event info
• News & Notices

Shimadzu Review Vol.77[3・4] Food Safety and Food Health

• News & Notices

1st Half Results & Financial Position for the Fiscal Year Ended March 2022, Q&A session Transcript (Summary)

• Investor

Earnings Report for the six months ended September 30, 2021

• Investor

Notice of dividends from surplus (Interim Dividend) and revised Year-end dividend forecast

• Investor

DATABOOK

• Investor

Shimadzu Solutions for Patient and Healthcare Worker Safety

• Product & Event info

Antibody monitoring technology using mass spectrometry contributed to a determination of clinical outcomes for the treatment of rheumatoid arthritis by Kyoto University Hospital and Shimadzu Corporation

• News & Notices

In Collaboration with the NCVC, Establishment of the World’s First Technique for Detecting a Genetic Risk Factor for Cerebrovascular Disease Unique to East Asia
Shimadzu Techno-Research Commences a Contract Analysis Service for Medical Institutions for Research Purposes Only

• News & Notices

Invitation for RSNA2021(Radiological Society of North America) exhibition

• Product & Event info

Release of the EDX-7200 Energy Dispersive X-Ray Fluorescence Spectrometer
Improves Upon Best-Selling Model with Higher Speed, Higher Sensitivity, and Easier Operability

• Product & Event info
• News & Notices

Mass spectrometry technology contributed to a biomarker discovery for antibody therapeutics in cancer immunotherapy
Discovering a Biomarker for the Clinical Outcome of Cancer Patients treated with ipilimumab by Providence Cancer Institute, USA and Shimadzu Corporation

• News & Notices

Shimadzu Integrated Report 2021

• Investor

Corporate Governance Policy (Revised)

• Investor

Release of the Xslicer SMX-1010 and Xslicer SMX-1020 Microfocus X-Ray Inspection Systems

• Product & Event info
• News & Notices

Growth Strategy for Medical Systems Business

• Investor

Shimadzu Releases the SyncTraX™ (SMART version), Radiation Therapy Support System for Cancer
System Determines Irradiation Positioning Accurately and in Short Time Even during Treatment, which Reduces Total Treatment Time

• News & Notices

Contributing to PCR Screening Tests for Mutant Strains
Release of SARS-CoV-2 Mutation Assay Core Kit and Primer/Probe Mixes

• News & Notices

Shimadzu and HORIBA Release LC-Raman System
Merging Separating and Visualizing Technologies Offers New Value for R&D Applications in a Wide Variety of Fields

• News & Notices

1st Quarter Results & Financial Position for the Fiscal Year Ended March 2022 (FY 2021)

• Investor

Earnings Report for the three months ended June 30, 2021

• Investor

DATABOOK

• Investor

Realizing Stress-Free Radiography Even in Pandemics, Disasters, or Other Emergent Circumstances
- Release of Mobile X-Ray System MobileArt Evolution MX8 Version -

• Product & Event info
• News & Notices

Shimadzu Releases Amyloid MS CL System for Measuring Candidate Substance Potentially Causing Alzheimer’s Disease
System Requires Testing Only a Small Quantity of Blood, which Reduces Burden to Patients

• News & Notices

New Hydraulic Equipment Plant Completed to Meet Expanding Demand for Forklifts in China

• News & Notices

Rapid, Robust LC-MS/MS Analysis of Biomarker Candidates that Show a Correlation to Increase Severity of COVID-19 Symptoms
Release of Method Package for Modified Nucleoside Analysis System

• Product & Event info
• News & Notices

Updated the Corporate Governance page

• Investor

NOTICE OF RESOLUTIONS AT THE 158TH ANNUAL GENERAL MEETING OF SHAREHOLDERS

• Investor

Switch to Renewable Energy at Major Domestic Locations
Promoting the use of renewable energy for electricity use as declared in RE100

• News & Notices

Rakuten Medical and Shimadzu Corporation announce a joint development and commercialization agreement on a medical device to be used with the Illuminox™ platform

• News & Notices

Notice Regarding the Signing of Basic Agreement of Business Partnership between SHIMADZU and SHIONOGI for Wastewater Surveillance for Viruses in the Field of Infectious Diseases, Including Novel Coronavirus

• News & Notices

Mass spectrometry technology contributed to the advancement of cancer immunotherapy
Discovering a Biomarker for Predicting the Clinical Outcome of Cancer Patients treated with a New Combination Immunotherapy in a Phase I Clinical Trial Conducted by Providence Cancer Institute, USA

• News & Notices

NOTICE OF THE 158TH ANNUAL GENERAL MEETING OF SHAREHOLDERS

• Investor

FY2020-2022 Medium-Term Management Plan(Version Updated Due to the COVID-19 Pandemic:Adjusted Upward)

• Investor

FY2020 Operating Results & Financial Position, Q&A session transcript(summary)

• Investor

Earnings Report for the fiscal year ended March 31, 2021

• Investor

Notice Regarding Dividends of surplus

• Investor

Fact Book 2021, DATABOOK

• Investor

Shimadzu Scientific Instruments to Collaborate on Anti-aging Research at Washington University School of Medicine

• News & Notices

Shimadzu Wins Germany’s iF DESIGN AWARD 2021 for Three Products
Mass Spectrometer, Mass Microscope, and Environmentally Friendly Packaging Box

• News & Notices

Digital Mobile X-ray System MobileDaRt series exceeded 6,000 units worldwide sales

• Product & Event info

Shimadzu Mass Spectrometer Receives “Best of the Best Award” and Mass Microscope Receives the “Red Dot Award”!
- Red Dot Design Award 2021 -

• News & Notices

Shimadzu Joins the Global Environmental Initiative RE100
Aiming to Source 100 % Renewable Electricity

• News & Notices
• Investor

For the Fifth Consecutive Year, Shimadzu was Selected as a Nadeshiko Brand that Actively Empowers Women within the Company

• News & Notices
• Investor

First Time Selected as “Health and Productivity Management” Brand and Fifth Consecutive Year Certified as a “White 500” Company with Outstanding Health and Productivity Management Practices

• News & Notices
• Investor

Release of World’s First TOF-PET System Specialized for Head and Breast Examinations
Scanning Brain Tumors, Epilepsy and Breast Cancers with Outstanding Accuracy and Even Supporting Alzheimer’s and Other Dementia Researches

• News & Notices

Notice of Changes in Executive Members

• Investor

Shimadzu Introduces SPM-Nanoa Scanning Probe Microscope
Provides High-Level Operability and High-Speed Processing, with Automated Optical Adjustments and Observation Conditions Settings

• Product & Event info
• News & Notices

Release of the Novel Coronavirus Detection Kit for Wipe Tests
Allows quick and easy detection of the novel coronavirus on touch screens, doorknobs, etc. for efficient health and safety management

• News & Notices

3rd Quarter Results & Financial Position for the Fiscal Year Ended March 2021, Q&A session Transcript(summary)

• Investor

Improved Functionality Supports Working Remotely
Shimadzu’s New AOC-30 Series Automatic Sample Injection System for Gas Chromatographs

• Product & Event info
• News & Notices

Earnings Report for the nine months ended December 31, 2020

• Investor

Notice regarding Revised Forecasts of the year-end Dividend

• Investor

DATABOOK

• Investor

Changi General Hospital and Shimadzu (Asia Pacific) jointly launch centre to conduct mass spectrometry-based clinical testing and research for personalised treatment

• News & Notices

Sales of Novel Coronavirus PCR Testing Reagent Kits outside Japan Exports Began

• News & Notices

Initiation of Contract Analysis Services for the Automotive Industry with Foxconn, an Affiliate of Hon Hai: Joint Operation of Allied Laboratories at 22 Locations in China

• News & Notices

Shimadzu signs a collaboration agreement with TOTAL, a major Energy player and two European universities.
Toward the Development of an Innovative "Oxygenated compound analysis system" for Biofuel Research

• News & Notices

Growth Strategy for Analytical & Measuring Instruments Business

• Investor

Celebrating 60th Anniversary of Remote-controlled Fluoroscopy System

• Product & Event info